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Abstract
Mutations in low-density lipoprotein receptor-related protein 5 (Lrp5) impair retinal angiogenesis in patients with familial
exudative vitreoretinopathy (FEVR), a rare type of blinding vascular eye disease. The defective retinal vasculature phenotype
in human FEVR patients is recapitulated in Lrp5 knockout (Lrp5
2/2) mouse with delayed and incomplete development of
retinal vessels. In this study we examined gene expression changes in the developing Lrp5
2/2 mouse retina to gain insight
into the molecular mechanisms that underlie the pathology of FEVR in humans. Gene expression levels were assessed with
an Illumina microarray on total RNA from Lrp5
2/2 and WT retinas isolated on postnatal day (P) 8. Regulated genes were
confirmed using RT-qPCR analysis. Consistent with a role in vascular development, we identified expression changes in
genes involved in cell-cell adhesion, blood vessel morphogenesis and membrane transport in Lrp5
2/2 retina compared to
WT retina. In particular, tight junction protein claudin5 and amino acid transporter slc38a5 are both highly down-regulated
in Lrp5
2/2 retina. Similarly, several Wnt ligands including Wnt7b show decreased expression levels. Plasmalemma vesicle
associated protein (plvap), an endothelial permeability marker, in contrast, is up-regulated consistent with increased
permeability in Lrp5
2/2 retinas. Together these data suggest that Lrp5 regulates multiple groups of genes that influence
retinal angiogenesis and may contribute to the pathogenesis of FEVR.
Citation: Chen J, Stahl A, Krah NM, Seaward MR, Joyal J-S, et al. (2012) Retinal Expression of Wnt-Pathway Mediated Genes in Low-Density Lipoprotein Receptor-
Related Protein 5 (Lrp5) Knockout Mice. PLoS ONE 7(1): e30203. doi:10.1371/journal.pone.0030203
Editor: Amy C. Y. Lo, The University of Hong Kong, Hong Kong
Received August 23, 2011; Accepted December 12, 2011; Published January 17, 2012
Copyright:  2012 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by funding from Knights Templar Eye Foundation, Children’s Hospital Boston Manton Center for Orphan Disease Research
Innovation Fund, Juvenile Diabetes Research Foundation International, Charles H. Hood Foundation Child Health Research Award (to JC), National Institutes of
Health (EY017017, EY017017-04S1), V. Kann Rasmussen Foundation, Children’s Hospital Boston Mental Retardation and Developmental Disabilities Research
Center, Research to Prevent Blindness Senior Investigator Award, Alcon Research Institute Award, MacTel Foundation and Roche Foundation for Anemia Research
(LEHS). AS is supported by the Deutsche Forschungsgemeinschaft. PS holds a Canada Research Chair in Retinal Cell Biology and is supported by the Canadian
Institutes of Health Research. Microarray studies were performed by the Molecular Genetics Core Facility at Children’s Hospital Boston supported by NIH-P50-
NS40828, and NIH-P30-HD18655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: lois.smith@childrens.harvard.edu
Introduction
Familial exudative vitreoretinopathy (FEVR) is a rare
hereditary eye disease with abnormalities in retinal vascular
development [1]. Retinal blood vessel development in humans
normally starts during the fourth month of gestation and is
completed just before birth [2,3]. Infants with FEVR, in contrast,
are born with an incomplete retinal vasculature, leaving the
peripheral retina avascular. At the same time, hyaloid vessels, an
embryonic ocular vascular bed that normally regresses after
birth, persists in FEVR patients [4]. In the most severe cases of
FEVR, blindness results from tractional retinal detachments as a
consequence of hypoxia-induced neovascularization secondary to
incomplete retinal vascularization. Similar abnormalities in
retinal vasculature are also observed in patients with X-linked
Norrie disease [5,6].
Genetic studies have linked FEVR, Norrie disease and Coats’
disease with mutations in genes encoding components of the Wnt
signaling pathway, known to be involved in development and
disease [7,8,9]. Low-density lipoprotein receptor-related protein 5
(Lrp5), a Wnt co-receptor, is implicated in both autosomal
dominant and recessive forms of FEVR [10,11]. In addition, the
Wnt receptor frizzled4 is linked to autosomal dominant FEVR
[12,13], and the Wnt ligand Norrin is associated with Norrie
disease, Coats’ disease and X-linked recessive FEVR [14,15,16].
Canonical Wnt signaling starts with binding of Wnt ligands, a
group of small proteins to an activated Wnt receptor complex
composed of Frizzled and Lrp5/6. Wnt ligand binding stabilizes b-
catenin in the cytoplasm of the activated cell from where it
translocates to the nucleus and binds nuclear T-cell factor/
lymphoid enhancer factor (TCF/LEF) to control activation of
Wnt-responsive genes [8].
The ocular phenotype of human FEVR disease is replicated in
Lrp5 deficient mice [17,18]. In addition, Lrp5
2/2 mice also have
low bone density and persistent embryonic hyaloid vessels in the
eye [17,18], recapitulating human autosomal-recessive osteoporo-
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to humans, retinal vasculature in mice develops postnatally which
makes the Lrp5
2/2 mouse a useful experimental model for
studying Wnt signaling and the pathogenesis of FEVR [19,20].
Similar to human FEVR patients, the retina of Lrp5
2/2 mice
displays delayed vessel growth in the peripheral retina [21] and
lack of deep layers of retinal capillary networks [19,20].
Inadequate vascularization in the retina contributes to the
subsequent formation of hypoxia-driven microaneurysm-like
vascular lesions [22], also mimicking those observed in human
FEVR patients. As additional proof that the Wnt pathway is
important in the pathologic events leading to FEVR, delayed and
incomplete retinal vascular development is also observed in
Norrin
2/2 and Frizzled4
2/2 mice [16,23] which lack other
elements of the Wnt pathway.
The purpose of this study is to analyze gene expression
changes triggered by the absence of Wnt signaling in Lrp5
2/2
mouse retinas. Analysis of gene expression in a mouse model of
FEVR is important considering that there is no human retinal
expression data available in FEVR patients. Since Lrp5
2/2
retinas lack the Lrp5-mediated activation of Wnt-responsive
genes, any differentially regulated genes identified between
WT and Lrp5
2/2 mouse can be potential mediators of Wnt-
driven regulation of retinal blood vessel growth. Detailed
analysis of these differentially regulated genes therefore has the
potential to help elucidate the molecular events leading to the
defective retinal vascular phenotype observed in human FEVR
patients.
Results
Delayed retinal vascular development and persistent
hyaloid vessels in Lrp5
2/2 mice
Characterization of Lrp5
2/2 retinas revealed delayed outgrowth
of the superficial capillary network at P8 with retinal vessels
covering 69.362.7% of the total retinal area, compared with
92.261.5%inWTretinas(n=5–10pergroup;p#0.0001,Fig.1A),
suggesting that loss of Lrp5 causes delayed retinal vascular growth,
similartothatseeninNorrin
2/2 and Frizzled4
2/2retinas[21,23].As
the retinal vasculature develops, hyaloid vessels, an embryonic
vascular bedthat providesnutrientstothedeveloping lens,normally
regress after birth. In Lrp5
2/2 eyes, however, persistent hyaloid
vessels are seen at P8 compared with WT retina (Fig. 1B),
suggesting a defect in hyaloid regression in the absence of Lrp5.
Defective retinal vasculature and lack of deep layer
vascular networks in Lrp5
2/2 retina
At P12, Lrp5
2/2 retinas start to develop dilated vessels with
enlarged microaneurysm-like lesions in the superficial layer
(Fig. 2A). Progression of these lesions is seen at P17 (Fig. 2A),
and the lesions persist into adulthood [22]. Development of
intermediate and deep retinal capillary networks in inner and outer
plexiform layers normally begins around P8 and is completed by
P21 in WT mice. However, Lrp5
2/2 retinas fail to form these
deeper layers of capillary vessels, as shown in retinal crosssections of
adult mice (Fig. 2B). A similar absence of the retinal vascular
network has also been reported in homozygous Lrp5
r18 mice with
Figure 1. Delayed development of the superficial retinal vasculature and persistent hyaloid vessels in Lrp5 null mice. (A) Left: retinal
whole mounts stained with isolectin B4-594 from WT and Lrp5 null mice at post-natal day (P) 8. Right: quantification of vascularized retinal area in WT
and Lrp5 null mice at P8. n=5–10 per group, ***p,0.001. (B) Retinal cross sections of WT mice and Lrp5 null mice at P8 stained for endothelial cells
with isolectin B4-594 (red) and cell nuclei (DAPI, blue). Arrows indicate persistent hyaloid vessels in Lrp5 null retina. Scale bars: 500 mm.
doi:10.1371/journal.pone.0030203.g001
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sprouting angiogenesis inthe deep layers of the retinal capillary bed.
Decreased vascular density in Lrp5
2/2 brain
The decreased vascular growth in the retina likely reflects
reduced overall vascular density in the central nervous system. We
stained brain sections from Lrp5
2/2 and WT mice with isolectin to
assess brain vessel density. At P8, vascular density in the forebrain
is less in Lrp5
2/2 mice compared with wild type mice (Fig. 2C).
Defective CNS angiogenesis is also observed in Frizzled4
2/2 mice
[16], as well as in Wnt7a
2/2 and Wnt7b
2/2 mice with disruption
of Wnt signaling [24,25], suggesting that the Wnt signaling
pathway is critical for blood vessel growth in the central nervous
system. This agrees with the clinical observations in Norrie disease
patients with vascular defects in the cerebellum, impaired motor
skills and mental retardation [6].
Expression of Lrp5, Norrin, Frizzled4 and Disheveled
during development of wild type retina
To understand the temporal expression of Wnt ligands and
receptors in the retina, we assessed expression levels of the Wnt
ligand Norrin as well as expression of the receptors Frizzled4 and
Lrp5 during normal development in wild type mouse retina.
From P1 to P17, Lrp5 mRNA expression decreases (Fig. 3A),
consistent with a role for Lrp5 during neovessel development as
opposed to expression in mature vessels [22]. In contrast, the
expression level of Wnt receptor Frizzled4 tends to increase as the
retina develops (Fig. 3B). Norrin expression levels, on the other
hand, remains relatively unchanged from P1 to P17 (Fig. 3C).
These changes may reflect complex interactions between
multiple Wnt ligands and receptors that occur during retinal
development. Other Wnt ligands such as Wnt7b, and Frizzled
receptors other than Frizzled4, eg. Frizzled5, are also important
for vascular and neuronal development in the eye, and may
interact with Lrp5 [26,27]. In addition, Norrin and Frizzled4
may also bind Lrp6, another Wnt co-receptor with essential
functions for eye development [28]. Moreover, we also assessed
expression of disheveled (Dvl), a cytoplasmatic phospho-protein
that is required for Wnt signaling. Dvl2 shows remarkably similar
decreasing expression pattern as Lrp5, while as Dvl1 and Dvl3
does not show substantial changes during development
(F i g u r e3 D ,E ,F ).
Figure 2. Abnormal vascular development in the inner and outer retina and forebrain of Lrp5 null mice. (A) Retinal whole mounts of WT
and Lrp5 null mice stained for endothelial cells with isolectin B4-594 at P12 and 17. Enlarged images highlight the abnormal vessel growth in the Lrp5
null retina. (B) Retinal cross sections from P30 WT and Lrp5 null mice stained for endothelial cells with isolectin B4-594 (red) and cell nuclei with DAPI
(blue). Arrows indicate deep layers of retinal vasculature which is present in WT retina but absent in Lrp5 null retina. (C) Cross sections of the forebrain
from P8 WT and Lrp5 null mice with endothelial cells stained with isolectin B4-594. Scale bar: 100 mm.
doi:10.1371/journal.pone.0030203.g002
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2/2 eye
To assess candidate genes differentially expressed in Lrp5
2/2
retinas, we examined a gene expression microarray (Illumina
mouse-6 expression BeadChip) of P8 Lrp5
2/2 retinas and WT
control retinas (n=3 per group). P8 is chosen because the
development of deeper retinal vessel networks, defective in Lrp5
2/
2 retina, begins at P8. Among ,45,000 probe sequences on the
array, 11,790 expressed probes were detected. After initial quality
control, background analysis and normalization with Bead Studio
software, the array data was further analyzed using the SAM
program (Significant Analysis of Microarray) [29]. Using p,0.05
and a 1.3 fold change cutoff between gene expression in Lrp5
2/2
compared to WT retinas with an estimated false discovery rate of
,19%, we identified 80 genes down-regulated and 13 genes up-
regulated. These genes were grouped using Gene Ontology and
the most significantly regulated gene groups are summarized in
Table 1. Among the most altered are cell adhesion molecules,
membrane transporters, and molecules involved in blood vessel
growth and morphogenesis. Tight junction protein claudin5
(Cln5), an endothelial specific protein that plays a critical role in
maintaining blood retinal barrier (BRB) [30], is significantly down-
regulated about 9 fold in Lrp5
2/2 retina. Slc38a5 (solute carrier
family 38, member 5), a system N sodium-coupled amino acid
transporter, is similarly down-regulated 7 fold. Other mRNAs
down-regulated in Lrp5
2/2 retinas include major facilitator
superfamily domain containing 2 (Mfsd2) (,3 fold), gap junction
membrane channel protein alpha 1 (Gja1) (,2 fold) and
transcription factor Sox18 (,1.4 fold). Two mRNAs significantly
up-regulated in Lrp5
2/2 retinas are plasmalemma vesicle
associated protein (Plvap), a marker for fenestrated blood vessel
associated with increased vascular permeability [31,32], and
epithelial membrane protein 1 (EMP1). To illustrate expression
levels of identified genes, heat maps were generated for claudin
family proteins, membrane transporters, cell adhesion proteins
and blood vessel growth factors (Fig. 4). Among 10 members of
the claudin family of genes, only Cln5 is significantly regulated in
the absence of Lrp5. The down-regulation of tight junction protein
Cln5 and increased expression of Plvap are consistent with the
observed increased vascular permeability in Lrp5
2/2 retinas
[20,22]. It is important to note that several of the most significantly
regulated genes (Cln5, Scl38a5, Mfsd2, Plvap) are also similarly
regulated in Norrin
2/2 retinas [33] (Table 2), suggesting the
possibility that the related retinal vascular phenotype observed in
Lrp5
2/2 and Norrin
2/2 mice is mediated by common molecular
mechanisms in the absence of different Wnt signaling pathway
components.
Validation of selected genes with RT-qPCR
To validate the genes identified with microarray analysis, we
performed RT-qPCR to assess mRNA expression level of
Figure 3. Expression levels of Lrp5, Norrin, Frizzled4 and Dvl mRNA during retinal development in wild type mice. Quantification of
mRNA (A) Lrp5, (B) Norrin, (C) Frizzled4, (D) Dvl1, (E) Dvl2, and (F) Dlv3 was performed with RT-qPCR during normal retinal development from P1-P17.
Expression levels were normalized against house keeping gene Cyclophilin A. Trend lines were fitted with polynomial, linear or power regression.
doi:10.1371/journal.pone.0030203.g003
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mRNA levels to be significantly down-regulated in Lrp5
2/2
retinas, by 5 fold and 6 fold respectively (Fig. 5A). Significant
down-regulation was also verified for Gja1 (,3 fold), Mfsd2 (,5
fold) using RT-qPCR (Fig. 5B). Transcription factor Sox18 is
significantly down-regulated on qPCR (,1.5 fold), with vWF
showing a trend of down –regulation (1.4 fold) (Fig. 5B).
Similarly, qPCR analysis validated increased expression of Plvap
(,4f o l d )i nLrp5
2/2 retinas (Fig. 5C). The increased regulation
of EMP1 can not be confirmed with RT-qPCR, suggesting that
EMP1 is likely one of the false positive discovery from gene
array. Together these data confirm differential expression of the
top candidate genes identified with microarray in Lrp5
2/2
retinas. Expression levels of these genes are likely regulated
either directly as transcription targets of Wnt signaling in cells
that normally express LRP5, or through secondary effects
responding to primary changes in retinal vascular and neuronal
defects in the absence of Lrp5.
Regulation of Wnt ligands in Lrp5
2/2 retina
To assess whether components of the Wnt pathway are regulated
in Lrp5
2/2 retinas, we assessed Wnt ligands, receptors and other
downstream effectors in gene array and found no substantial
changes (Fig. S1). In order to corroborate these findings, we
screened with RT-qPCR expression levels of several Wnt ligands in
Lrp5
2/2 and WT retinas at P8. Interestingly we found Norrin levels
tobeslightlyincreasedinLrp5
2/2retinascomparedtoWT(Fig.6).
In contrast, the ligands Wnt5a and Wnt10b are both significantly
down-regulated by 2–4 fold in Lrp5
2/2 retinas compared to WT
(Fig. 6). In particular, Wnt7b level is significantly down-regulated
by .10 fold (Fig. 6). Wnt7b secreted by macrophages is implicated
in regulation of hyaloid regression [26]; hence decreased Wnt7b
levels are likely associated with or contribute to the observed
persistence of hyaloid vessels in Lrp5
2/2 eyes.
Discussion
In this study we assessed gene expression changes in Lrp5
2/2
retinas, which may contribute to the delayed and incomplete
retinal vascular development in the absence of Lrp5. We found
Lrp5
2/2 retinas have delayed growth of the superficial layer of
retinal vessel and persistant hyaloid vessels. Lrp5
2/2 retinas also
fail to develop deep layers of retinal capillary networks. As the
retina grows and becomes metabolically active, tissue ischemia and
hypoxia occur, resulting in abnormal aggregative endothelial
lesions in the superficial layer staring from P12 and persisting into
adulthood. These cellular changes correspond to visual function
deficiency in Lrp5 loss of function mutant mice [19]. Previous
studies have reported presence of Lrp5 in retinal vascular
endothelial cells and Muller cells [19,22], suggesting these cells
are likely most impacted by lack of Lrp5 to cause the defective
retinal vascular and functional phenotype in Lrp5
2/2 mice.
The most significantly regulated genes found in Lrp5
2/2 retina
include cell adhesion proteins, membrane transporters and genes
involved in blood vessel growth and morphogenesis. Of particular
interest is the tight junction protein Cln5 which is down-regulated
in Lrp5
2/2 retinas approximately 9 fold. Previous studies have
found that Cln5 is regulated in a Wnt dependent manner via ß-
catenin [22,34]. Regulation of Cln5 by Wnt signaling is likely
mediated by transcription factor Sox18 [22] which is also
significantly down-regulated in the Lrp5
2/2 retina. A previous
study from our group found that blocking Cln5 significantly
suppresses blood vessel endothelial cell growth [22], suggesting
that the defective vascular phenotype of Lrp5
2/2 retinas is likely
attributable in part to Cln5 deficiency. As an integral part of tight
junctions, Cln5 may be essential for endothelial cell adhesion, tube
formation and organized migration of endothelial cells. Impor-
tantly in this context, Cln5 is also significantly down-regulated in
Norrin
2/2 retinas to a similar extent [33], raising the possibility
that Cln5 may mediate common molecular events underlying
similar retinal vascular defects in the absence of Wnt signaling.
We found that Slc38a5, an amino acid transporter expressed
mainly in Muller cells, ganglion cells and endothelial cells
[19,35,36], is also significantly down-regulated in Lrp5
2/2 retinas
confirming previous reports. Interestingly, Slc38a5 is down-
regulated to a similar extent in Norrin
2/2 retinas [33]. Slc38a5 is
a neutral amino acid transporter responsible mostly for glutamine
uptake in the retina. It is not yet clear whether the Lrp5
2/2 retina
has a deficiency in glutamine transport or glutamate synthesis.
However, Lrp5
r18 mutant mice have reduced b-wave ERG
Table 1. Selected groups of genes regulated in Lrp5
2/2
retina.
Genes:
Fold change
in Lrp5
2/2 retina
Cell Adhesion/Junction
claudin 5 (Cldn5) (2) 8.97
Von Willebrand factor homolog (Vwf) (2) 2.56
secreted phosphoprotein 1 (Spp1) (2) 2.32
CD93 antigen (CD93) (2) 1.89
procollagen, type XVIII, alpha 1 (Col18a1) (2) 1.72
endothelial cell-specific adhesion molecule (Esam1) (2) 1.73
endothelial-specific receptor tyrosine kinase (Tek) (2) 1.48
connective tissue growth factor (Ctgf) (2) 1.55
intercellular adhesion molecule 2 (Icam2) (2) 1.31
vinculin (Vcl) (2) 1.29
plasmalemma vesicle associated protein (Plvap) (+) 1.78
epithelial membrane protein 1 (EMP1) (+) 2.08
Membrane Transporter
solute carrier family 38, member 5 (Slc38a5) (2) 7.11
major facilitator superfamily domain containing 2 (Mfsd2) (2) 3.26
solute carrier family 40 (iron-regulated transporter),
member 1 (Slc40a1)
(2) 2.22
gap junction membrane channel protein alpha 1 (Gja1) (2) 2.05
solute carrier family 3, member 4 (Slc3a4) (2) 2.01
solute carrier organic anion transporter family, member
2b1 (Slco2b1)
(2) 1.92
receptor (calcitonin) activity modifying protein 2 (Ramp2) (2) 1.53
Blood vessel development/morphogenesis
gap junction membrane channel protein alpha 1 (Gja1) (2) 2.05
procollagen, type XVIII, alpha 1 (Col18a1) (2) 1.72
endothelin receptor type A (Ednra) (2) 1.49
bone morphogenetic protein 4 (Bmp4) (2) 1.42
gap junction protein, alpha 4 (Gja4) (2) 1.42
EGF-like domain 7 (Egfl7) (2) 1.38
SRY-box containing gene 18 (Sox18) (2) 1.38
Note: Retinas were isolated from P8 Lrp5
2/2 mice and age matched WT control
mice. RNA was isolated and assessed with Illumina gene expression microarray.
(2) indicates decreased expression in Lrp5
2/2 retina and (+) indicates increased
expression in Lrp5
2/2 retina compared to WT control.
doi:10.1371/journal.pone.0030203.t001
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inner retina and may be associated with loss of the glutamate
transporter [19,37]. Whether down-regulation of slc38a5 is linked
to the impaired retinal vascular development and neuronal
function in Lrp5
2/2 retina needs further investigation.
Plvap, a vascular permeability marker, is highly up-regulated in
Lrp5
2/2 retina, likely reflecting increased breakdown of the blood
retinal barrier [20,22]. Loss of Wnt signaling is associated with
decreased blood barrier integrity not only in the retina but also in
the central nervous system in the absence of Wnt ligands Wnt7a
Figure 4. Regulation of tight junction, membrane transport, angiogenic, and cell adhesion genes in the Lrp5 null retina. Heat maps
illustrate the results of a gene array run from whole retinal total mRNA. The most regulated families of genes were (A) claudin family genes, (B)
membrane transport genes, (C) angiogenic regulatory genes, and (D) cell adhesion/cell-cell junction genes. Each sample is represented by a block:
either wild-type (WT) samples 1 through 3, and Lrp5 null samples 1–3. Relative down-regulation of expression in Lrp5 null retina compared to WT
retina is represented by green, while relative up-regulation is in red. No relative regulation is black (See scale on Figure).
doi:10.1371/journal.pone.0030203.g004
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impairment in blood brain barrier function and increased vascular
leakage [16,21]. In Lrp5
2/2 retinas, the observed BRB breakdown
may be precipitated by decreased levels of Cln5, an essential
component of tight junctions [30]. This is consistent with the
observation of impaired blood brain barrier function in Cln5
2/2
mice [38].
The genes identified in this study may not only help to
understand the abnormal retinal vascular development in Lrp5
2/2
eyes, but also elucidate the molecular basis of persistent hyaloid
vessels observed in Lrp5
2/2 eyes. Expression levels of Wnt7b,
which has been implicated in macrophage-mediated hyaloid vessel
regression [26], is found to be significantly down-regulated in
Lrp5
2/2 eyes. Hence, persistent hyaloid vessels in Lrp5
2/2 eyes
may be partially attributable to Wnt7b deficiency. Persistent
hyaloid vessels often occur in association with delayed retinal
vascular development in both humans and mice. It remains,
however, debatable which process, hyaloid regression or delayed
retinal vessel growth, is the primary event. It is conceivable that
inadequate retinal vascular growth can cause retinal hypoxia
which impedes regression of hyaloid vessels [39]. On the other
hand, persistent hyaloid vessels can also suppress the hypothesized
‘‘physiologic hypoxia’’ required for normal retinal vascular
development [40,41]. Interestingly, mice with conditional deple-
tion of VHL (von Hippel-Lindau tumor suppressor protein), which
is essential for HIF (hypoxia-inducible factor) signaling, develop
persistent hyaloid vasculature [42]. This phenotype is similar to
mice with loss of Wnt signaling. Recently a study showed HIF1a
can negatively regulate Wnt/ß-catenin activity [43]. Together
these data suggested oxygen-sensing mechanisms likely play a
significant role in the process of hyaloid regression and retinal
vessel development, and Wnt signaling may act synergistically with
oxygen-sensing pathways to mediate both hyaloid vessel regression
and retinal vascular development.
As Wnt signaling is implicated in many biological processes
during development and disease, it is sensible to question whether
Wnt signaling acts beyond the hereditary retinopathies to play a
role in other more prevalent, postnatally occurring retinopathies
such as retinopathy of prematurity (ROP) and diabetic retinop-
athy. Our previous work indicates that Wnt signaling affects not
only vascular growth during retinal development but also
pathologic neovascularization in proliferative ischemic retinopathy
[22]. Studies from other groups also show that Wnt signaling
affects inflammation and oxidative stress in animal models of
diabetic retinopathy [44,45,46] and age-related macular degener-
ation [47]. Targeting Wnt signaling pathway, therefore, appears to
be an appealing approach to prevent and treat not only genetic eye
disorders such as FEVR, but also other vascular eye diseases.
Table 2. Common genes regulated in Lrp5
2/2 and Norrin
2/2
retinas.
Fold change
Genes: Lrp5
2/2
Norrin
2/
2*
Decreased
claudin 5 (Cldn5) (2) 8.97 (2) 2.03
solute carrier family 38, member 5 (Slc38a5) (2) 7.11 (2) 14.03
major facilitator superfamily domain
containing 2 (Mfsd2)
(2) 3.26 (2) 2.44
EGF, latrophilin seven transmembrane
domain containing 1 (Eltd1)
(2) 2.27 (2) 1.72
Apolipoprotein D (Apod) (2) 1.67 (2) 2.06
Angiotensin receptor-like 1 (Agtrl1) (2) 1.40 (2) 1.92
Adenomatosis polyposis coli
down-regulated 1 (Apcdd1)
(2) 1.25 (2) 1.66
Increased
plasmalemma vesicle associated protein (Plvap) (+) 1.78 (+) 1.86
Adrenomedullin (Adm) (+) 1.37 (+) 2.03
Note: Retinas were isolated from P8 Lrp5
2/2 mice and age matched WT control
mice. RNA was isolated and assessed with Illumina gene expression microarray.
(2) indicates decreased expression in Lrp5
2/2 retina compared to WT retina,
and (+) indicates increased expression in Lrp5
2/2 retina.
*: Genes regulated in P7 Norrin
2/2 retina were adapted from Schafer et. al. IOVS,
2009 [33].
doi:10.1371/journal.pone.0030203.t002
Figure 5. Confirmation of gene expression differentially
regulated in Lrp5 null retina with RT-qPCR. Quantification of
mRNA (A) Cln5 and Slc38a5, (B) Gja1, Msfd2, Sox18, and vWF, and (C)
Plvap and EMP1 in WT and Lrp5 null retina with RT-qPCR at P8.
Expression levels were normalized against housekeeping gene Cyclo-
philin A.* p,0.05, **p,0.01.
doi:10.1371/journal.pone.0030203.g005
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Animals
These studies adhered to the Association for Research in Vision
and Ophthalmology (ARVO) Statement for the Use of Animals in
Ophthalmic and Vision Research and were approved by the
Children’s Hospital Boston Animal Care and Use Committee
(animal protocol approval ID 10-08-1770R). Lrp5
2/2 mice (stock
no. 005823; Jackson Laboratory, developed by Deltagen Inc.) and
its wild type control C57Bl/6J mice (stock no. 000664; Jackson
Laboratory) were used for this study.
Retina dissection, vessel staining and flat mount
Mice at postnatal day 8, 12 and 17 were anesthetized with
Avertin (Sigma-Aldrich) and sacrificed by cervical dislocation.
Eyes were enucleated and fixed in 4% paraformaldehyde for 1 h
at room temperature, followed by isolation and dissection of the
retina. To visualize the retinal vasculature, retinas were stained
overnight at room temperature with fluoresceinated Griffonia
Bandeiraea Simplicifolia Isolectin B4 (Alexa Fluor 594 conjugated;
I21413; Invitrogen; 1:100 dilution) in 1 mM CaCl2 in PBS. After
2 h of washes in PBS, retinas were whole-mounted onto Super-
frost/Plus microscope slides (12-550-15; Fisher Scientific) with the
photoreceptor side down. Retinas were then imbedded in
SlowFade Antifade reagent (S2828; Invitrogen) to preserve the
stain. Retinal vasculatures were imaged with a Zeiss microscope.
Vascularized retinal areas were quantified with photoshop as
described previously [48,49,50].
Eye and brain sectioning and staining
For histochemistry, eyes and brains were enucleated and fixed
in 4% paraformaldehyde for 1 h at room temperature, followed by
removal of cornea and lens. The eye cups were subsequently
rinsed with PBS and placed in 30% sucrose overnight at 4uC,
embedded in OCT and frozen on dry ice. Retinal samples were
cryosectioned into 12-mm sections, and collected on slides. Sections
were stained with isolectin (1:100 in PBS with 1 mM CaCl2)t o
visualize vessels and mounted with Vectashield mounting medium
for fluorescence with DAPI (Vector Laboratories, Inc. Burlingame,
CA).
RNA isolation and cDNA preparation
For each time point, total RNA was extracted from the retinas
of 6 mice, each from a different litter. Retinas were lysed with a
mortar and pestle and filtered through QiaShredder columns
(Qiagen, Chatsworth, MD, USA). RNA was then extracted as per
manufacturer’s instructions using the RNeasy Kit (Qiagen). The
RNA was then pooled to reduce biologic variability (n=6). To
generate cDNA, 1 mg total RNA was treated with DNase I
(Ambion Inc.) to remove any contaminating genomic DNA, and
was then reverse transcribed using random hexamers, and
SuperScript III reverse transcriptase (Invitrogen Corp., Carlsbad,
CA, USA).
Gene expression microarray
Total retinal RNA was isolated from 3 Lrp5
2/2 and 3 WT
mice. Gene expression microarray analysis was performed using
an Illumina mouse gene microarray, with each sample being a
biological replicate (n=3 per group; Mouse-WG6 expression
BeadChip; Illumina, San Diego, CA). All data is MIAME
compliant and the raw data was deposited in a MIAME compliant
database (GEO, accession number GSE32145). The chip contains
,45,000 probe sets representing ,34,000 genes. Microarray
studies, from cDNA synthesis to raw data normalization were
performed by the Molecular Genetics Core Facility at Children’s
Hospital Boston. Briefly, total RNA (1 mg each) were reverse
transcribed, followed by a single in vitro transcription amplification
to incorporate biotin-labeled nucleotide, and subsequent hybrid-
ization and staining with strepatavidin-Cy3 according to the
manufacturer’s instructions. The chip was scanned with Illumina
BeadArray Reader to measure the signal intensity by the labeled
target. Raw data were analyzed with the microarray software
(Bead Studio Gene Expression version 3.4.0) for quality control,
background analysis and normalization with rank invariant
algorithm. Normalized data were further analyzed with the
SAM program (Significant Analysis of Microarray) [29] using
p,0.05 and a delta of 0.19. Resulting gene lists for both Lrp5
2/2
and WT retinas were grouped using online tool Gene Ontology
Enrichment Analysis Software (GOEAST Tools), which is hosted
by Institute of Genetics and Developmental Biology, Chinese
Academy of Sciences [51]. Heat maps demonstrating differential
gene expression were generated by adjusting the average signal of
each sample to their respective log10 values. The average of the
three WT signals was then used as the baseline for normal gene
expression. Each value from Lrp5
2/2 retina was normalized to the
average WT value and assigned a number between 21, which
represented downregulation, 0, which represented no gene
regulation, and +1, which represented upregulation. These values
were then plotted in Microsoft Excel and colors were assigned to
values using the Conditional Formatting function. Maps were then
imported into Adobe Illustrator (CS4) to enhance contrast and
resolution.
Quantitative real-time PCR analysis of gene expression
PCR primers targeting Lrp5 (F: 59-AAG GGT GCT GTG TAC
TGG AC-39, R: 5-AGA AGA GAA CCT TAC GGG ACG-39),
Frizzled4 (F: 59-TTC CTT TGT TCG GTT TAT GTG CC-39,
R: 59-CTC TCA GGA CTG GTT CAC AGC-39), Norrin (F: 59-
GTG AGG GGC ACT GCA GCC AG-39;R :5 9-CAG CGC
AGA CGC AGA GCC TT-39), Claudin5 (F: 59-GCA AGG TGT
ATG AAT CTG TGC T-39,R :5 9-GTC AAG GTA ACA AAG
Figure 6. Wnt ligands and receptor regulated in P8 Lrp5 null
retina. Wnt ligand Norrin, Wnt5a, Wnt7b, and Wnt10b mRNA
expression in WT and Lrp5
2/2 whole retinas were quantified with RT-
qPCR and normalized to Cyclophilin A expression. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0030203.g006
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ATT-39,R :5 9-CCT GTG AGG CAG ATA GTC CA-39), Wnt5a
(F: 59-CAA CTG GCA GGA CTT TCT CAA-39,R :5 9-CAT
CTC CGA TGC CGG AAC T-39), Wnt7b (F: 59-GGT GTG
GCA GTG TAC CTG CAA-39,R :5 9-GTG AAG ACC TCG
GTG CGC T-39), Wnt10b (F: 59-GAAGGGTAGTGGTGAG-
CAAGA-39,R :5 9-GGT TAC AGC CAC CCC ATT CC-39),
Gja1 (F: 59- ACA GCG GTT GAG TCA GCT TG-39,R :5 9-
GAG AGA TGG GGA AGG ACT TGT -39), EMP1 (F: 59- TTG
GTG CTA CTG GCT GGT CT -39,R :5 9- CAT TGC CGT
AGG ACA GGG AG-39), Mfsd2 (F: 59- AGA AGC AGC AAC
TGT CCA TTT -39,R :5 9- CTC GGC CCA CAA AAA GGA
TAA T-39), Sox18 (F: 59- ATG CCA CTA CAC TCC CCT ACC
A-39,R :5 9- CTG CTC TCT TCT GGA CAG GAC AT-39),
slc38a5 (F: 59- CAA CCT CAG CAA CGC TAT CAT-39,R :5 9-
CAG GTC CAA ATG CCC TCT G-39), Dvl1 (F: 59- ATG AGG
AGG ACA ATA CGA GCC-39,R :5 9- GCT TCC GAA CTA
GCC GAG AG-39), Dvl2 (F: 59- TGT CGT CAG ATA CCC
CAC AG-39,R :5 9- CTG GAT ACA TTA GGG TGG AAG GA-
39), Dvl3 (F: 59- ACA CGG AGA CCG ACT CCT T-39,R :5 9-
AGG GTA GAT GAA CTG TCA TAG CC-39), vWF (F: 59-
CAA TGG CAC CGT AAC GCA G-39,R :5 9- TGG AGA GCT
TAT AGT ACC CAG C-39) and an house keeping control gene,
Cyclophilin A (F: 59-AGG TGG AGA GCA CCA AGA CAG A-39,
R: 59-TGC CGG AGT CGA CAA TGA T-39), were designed
using Primer Bank and NCBI Primer Blast Software.Express
software (Applied BioSystems). We used three methods to analyze
primer sequences for specificity of gene detection. First, NCBI
Blast module was used to identify primer and probe sequences that
specifically detected the sequence of choice. Second, amplicons
generated during a PCR reaction were analyzed using the first
derivative primer melting curve software supplied by Applied
BioSystems. This analysis determines the presence of amplicons on
the basis of a specific melting point temperature. Third, amplicons
generated were gel purified and sequenced by the Children’s
Hospital Boston Core Sequencing Facility. This further confirmed
the selection of the desired sequence. Quantitative analysis of gene
expression was determined using an ABI Prism 7700 Sequence
Detection System (TaqMan) and the SYBR Green Master mix kit.
Standard curves for each gene were plotted with quantified cDNA
template during each real-time PCR reaction. Each target gene
cDNA copy number was normalized to 10
6 copies of the house
keeping gene, cyclophilin A using delta-delta CT method.
Statistics
Results are presented as mean6SEM for animal studies and
mean6SD for the non-animal studies. A 2-sample t test was used
as a post test unless otherwise indicated.
Supporting Information
Figure S1 Heat maps illustrating expression profiles of other
members of the Wnt pathway regulated in Lrp5 null retina in a
gene array run from whole retinal mRNA. The genes analyzed
include (A) Wnt ligands, (B) Wnt receptors, and (C) other
components downstream of Wnt signaling.
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